Renal hemodynamics disturbances in early stages of arterial hypertension in young patients
Abstract
Arterial hypertension (AH) is the most prevalent disease worldwide, with general population prevalence of 15-20%. Despite being typically diagnosed after the age of 50, recently AH becomes more prevalent in adolescents and young adults.
Aim. To identify the first clinical signs of renal pathology in young patients (under 35) with initial stages of AH.
Material and methods. Forty-two men with Stage I-III AH, aged 15-35 (mean age 21.7±5.6 years), were examined. AH duration varied from 1 to 7 years (3.6±3.0). Mean systolic blood pressure (BP) level was 149.35±9.03 mm Hg, diastolic BP – 93.48±5.32 mm Hg. In all participants, general clinical examination, renal dynamic angioscintigraphy with DTPA-Tc99m, and ophtalmoscopy were performed.
Results. Renal dynamic angioscintigraphy with DTPA-Tc99m revealed various renal hemodynamics abnormalities in 98% of the patients (n=41). In most individuals (94%; n=39), renal blood flow was reduced. Ophtalmoscopy revealed initial stages of hypertensive retinopathy in 22 patients (52%). Participants with hypertensive retinopathy experienced decrease in renal blood flow of Stage II-III more often, by 17%: the decline was registered in 77% and 50% of the patients with or without hypertensive retinopathy, respectively. Therefore, retinopathy was associated with more severe abnormalities of renal hemodynamics.
Conclusion. In early AH stages, young patients, aged under 35, experience vascular remodeling even with high BP anamnesis as short as 1-7 years. There is a need for early administration of antihypertensive therapy, especially ACE inhibitors.
About the Authors
I. G. FominaRussian Federation
E. N. Gavrilova
Russian Federation
T. A. Dyakova
Russian Federation
N. E. Gaidamakina
Russian Federation
References
1. Шальнова С.А., Деев А.Д., Оганов Р.Г., Шестов Д.Б. Роль систолического и диастолического артериального давления для прогноза смертности от сердечно-сосудистых заболеваний. Кардиоваск тер профил 2002; 1: 10.
2. Оганов Р.Г. Проблема контроля артериальной гипертонии среди населения. Кардиология 1994; 3: 80-3.
3. Лазебник Л.Б., Милюкова О.М., Комисаренко И.А. Блокаторы рецепторов ангиотензина II. Межведомственный научный совет по геронтологии и гериатрии РАМН и МЗ РФ. Москва 2001; 56.
4. Шляхто Е.В., Конради А.О. Причины и последствия активации симпатической нервной системы при артериальной гипертензии. Артер гиперт 2003; 9(3): 81-8.
5. Antonios TF, Singer DR, Markandu ND, et al. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999; 34: 655-8.
6. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension pre¬dicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart study. Am J Hypertens 1995; 8: 657-65.
7. Baumbach GL, Heistad DD. Adaptive changes in cerebral blood vessels during chronic hypertension. J Hypertns 1991; 9: 987-91.
8. Esler M. Sympathetic activity in experimental and human hypertension. In Mancia G. edc. Handbook of Hypertension, Vol 17. Amsterdam, Elsevier 1997; 628-73.
9. Ferrier C, Cox H, Elser M. Elevated total body Noradrenaline spillover in normotensive members of hypertensive families. Clin Sci 1993; 84: 225-30.
10. James CD, Baker PT. Human population biology and hypertension. In: Hypertension, pathophysiology, diagnosis and management (eds Laragh S.H., Brenner B.H.). New York: Raven Press 1990; 137-45.
11. Hamet P, Pausova Z, Trenllay J, Deng AY. Hypertension as a genetic disease. In: Manual of hypertension (eds. Mancia G.) London: Churchil Living Stone 2002; 50-75.
12. Hart M, Heistad D, Brody M. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension 1980; 2: 419-28.
13. Julius S. Changing role of the autonomic nervous system in human hypertension. J Hypertens 1990; 8: S59-65.
14. Kotchen JM, Kotchen TA, Guthrie GP, et al. Correlates of adolescent blood pres¬sure at five-year follow-up. Hypertension 1980; 2: 124-9.
15. Le Noble JLML, Tangelder GJ, Slaaf DW, et al. A functional morphometric study of the cremaster muscle microcirculation in young spontaneously hypertensive rats. J Hypertens 1990; 8: 741-8.
16. Mancia G, Bjorn Folkov Award Lecture. The sympathetic nervous system in hypertension. J Hypertens 1997; 15: 1553-65.
17. Mangoni AA, Mircoli L, Gianattassio С, et al. Effect of sympatectomy on mechanical properties of common carotid and femoral arteries. Hypertension 1997; 30: 1085-8.
18. Noon JP, Walker BR, Webb DJ, et al. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99: 1873-9.
19. Norrelund H, Christensen KL, Samani NJ, et al. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 1994; 24: 301-8.
20. Piccirilo G, Viоlа E, Nocco M, et al. Autonomic modulation of heart rate and blood pressure variability in normotensive offspring of hypertensive subjects. Lab Clin Med 2000; 135: 145-52.
21. Rizzoni D, Castellano M, Porteri E, et al. Vascular structural and functional alterations before and after the development of hypertension in SHR. Am J Hypertens 1994; 7: 193-200.
22. Squire IB, Reid JL. Interactions between the renin angiotensin system and autonomic nervous system. In Robertson JLS. The Renin Angiotensin System. Lon¬don: Gower 1993.
23. Williams PD, Puddey IB, Beilin LJ. Genetic influence on plasma catecholamines in human twins. J Clin Endocrinol metabolism 1993; 84: 225-30.
Review
For citations:
Fomina I.G., Gavrilova E.N., Dyakova T.A., Gaidamakina N.E. Renal hemodynamics disturbances in early stages of arterial hypertension in young patients. Cardiovascular Therapy and Prevention. 2005;4(3, ч.I):24-28. (In Russ.)